These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 13638638)
1. Phenylbutazone and its derivatives with special reference to G.27202. HART FD; BURLEY D Br Med J; 1959 Apr; 1(5129):1087-9. PubMed ID: 13638638 [No Abstract] [Full Text] [Related]
2. [Clinico-metabolic actoin of some phenylbutazone derivatives (G 27202, G 28315 and keto-phenylbutazone)]. CIRLA E; RATTI G Reumatismo; 1960; 12():76-80. PubMed ID: 13693726 [No Abstract] [Full Text] [Related]
3. [Comparative toxicity of various phenylbutazone derivatives]. DEROUAUX G; OLEFFE-KOOPMANSCH S C R Seances Soc Biol Fil; 1961; 155():1419-20. PubMed ID: 13885610 [No Abstract] [Full Text] [Related]
4. The status of G-27202 (metabolite 1 of phenylbutazone) in the treatment of rheumatic disorders. GRAHAM W Can Med Assoc J; 1960 May; 82(20):1005-8. PubMed ID: 13828827 [No Abstract] [Full Text] [Related]
5. [Effect of some phenylbutazone derivatives on various edematous reactions in the rat]. FRANCHIMONT P; LECOMTE J; van CAUWENBERGE H C R Seances Soc Biol Fil; 1960; 154():2383-6. PubMed ID: 13701213 [No Abstract] [Full Text] [Related]
6. [The influence of some phenylbutazone derivatives on the phenol red blood level in the rat]. KREPPEL E Med Exp Int J Exp Med; 1959; 1():285-9. PubMed ID: 14411946 [No Abstract] [Full Text] [Related]
7. [On the use and antiphlogistic therapeutic effectiveness of a metabolite of phenylbutazone in some disease processes of otorhinolaryngoiatric interest]. PAROLARI P Otorinolaringol Ital; 1961 Dec; 30():462-6. PubMed ID: 14484015 [No Abstract] [Full Text] [Related]
15. [Study of the effects of G-28315 on the course of gout]. de SEZE ; RYCKEWAERT A; LEVERNIEUX J Rev Rhum Mal Osteoartic; 1960; 27():44-6. PubMed ID: 14445313 [No Abstract] [Full Text] [Related]
16. [Results of the administration of sulfoxyphenylpyrazolidine (G 28, 315) in 25 patients with gout]. SERRE H; SIMON L; CLAUSTRE J Montp Med; 1959 Nov; 56():211-31. PubMed ID: 14445119 [No Abstract] [Full Text] [Related]
17. [Results of clinical experience with G 28,315 in the treatment of gouty patients]. FERNANDEZ DEL VALLADO P; GIJON BANOS J Rev Clin Esp; 1960 Apr; 77():5-10. PubMed ID: 13822295 [No Abstract] [Full Text] [Related]
18. [Treatment of gout by zoxazolamine and G-28315]. MERIEL P; RUFFIE R; FOURNIE A; AYROLLES C Therapie; 1960; 15():803-17. PubMed ID: 13769608 [No Abstract] [Full Text] [Related]
19. Influence of mofebutazone in comparison to phenylbutazone on the adenosine triphosphate level of polymorphonuclear cells and their migration. Partsch G Arzneimittelforschung; 1992 Nov; 42(11):1336-8. PubMed ID: 1492846 [TBL] [Abstract][Full Text] [Related]
20. [A new treatment of traumatic conditions, by metabolite I of phenylbutazone, or G-27202. Preliminary note]. WETTREICH W Hospital (Rio J); 1961 Dec; 60():895-902. PubMed ID: 14006389 [No Abstract] [Full Text] [Related] [Next] [New Search]